Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Muriel Paul"'
Autor:
Philippe Le Corvoisier, Muriel Paul, Laetitia Penso, Laura Pina Vegas, Pascal Claudepierre, Emilie Sbidian
Publikováno v:
Rheumatology
Rheumatology, Oxford University Press (OUP), 2022, 61 (4), pp.1589-1599. ⟨10.1093/rheumatology/keab522⟩
Rheumatology, Oxford University Press (OUP), 2022, 61 (4), pp.1589-1599. ⟨10.1093/rheumatology/keab522⟩
Objective Several biological DMARDs (bDMARDs) have demonstrated anti-inflammatory effects in PsA. However, their comparative cardiovascular safety profiles remain unknown. We evaluated the risk of major adverse cardiovascular events (MACEs) in PsA pa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f4ebc3a790a04adda3089ecf6386d58d
https://hal.archives-ouvertes.fr/hal-03692265
https://hal.archives-ouvertes.fr/hal-03692265
Autor:
Roger Rosario, Jacques Mansourati, Clément Delmas, Gwénolé Rohel, Pierre-André Natella, Sylvie Bastuji-Garin, Muriel Paul, Pascal Lim, Jean-Luc Dubois-Randé, Anne Bernard, Olivier Lairez, Bernard Tardy, Olivier Sanchez, Caroline Biendel, Nicolas Meneveau, Romain Gallet, Tabassome Simon, Pierre Coste, Hélène Bouvaist, Gilles Chatelier, Mustapha Sebbane, Fabrice Ivanes, Damien Fard, Richard Layese, Francis Couturaud
Publikováno v:
European Heart Journal: Acute Cardiovascular Care
European Heart Journal: Acute Cardiovascular Care, 2022, 11 (1), pp.2-9. ⟨10.1093/ehjacc/zuab082⟩
European Heart Journal: Acute Cardiovascular Care, 2022, 11 (1), pp.2-9. ⟨10.1093/ehjacc/zuab082⟩
Aims The role of diuretics in patients with intermediate-risk pulmonary embolism (PE) is controversial. In this multicentre, double-blind trial, we randomly assigned normotensive patients with intermediate-risk PE to receive either a single 80 mg bol
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2a5f2e4931ddf3cc0d78d71fba93e67d
https://hal.science/hal-03882615
https://hal.science/hal-03882615
Publikováno v:
Journal of Oncology Pharmacy Practice
Journal of Oncology Pharmacy Practice, 2021, 27 (4), pp.847-856. ⟨10.1177/1078155220940410⟩
Journal of Oncology Pharmacy Practice, 2021, 27 (4), pp.847-856. ⟨10.1177/1078155220940410⟩
Introduction The extended stability of the trastuzumab biosimilar Ogivri™ (MYL-1401O; trastuzumab-dkst) was studied under different storage conditions, including following reconstitution of the lyophilized powder (21 mg/mL) but undiluted and stored
Autor:
C. Forasassi, Agathe Raynaud-Simon, Luc Cynober, Ester Guery, C. Faure, Christian Aussel, Philippe Le Corvoisier, Alain Astier, Nathalie Neveux, Stéphane Herbaud, O. Bouillanne, Yves Boirie, Muriel Paul, J.-C. Melchior, Valérie Nivet-Antoine, Didier Chevenne, Stéphane Walrand, Florence Canoui-Poitrine
Publikováno v:
Clinical Nutrition
Clinical Nutrition, Elsevier, 2019, 38 (2), pp.564-574. ⟨10.1016/j.clnu.2018.02.017⟩
Clinical Nutrition, 2019, 38 (2), pp.564-574. ⟨10.1016/j.clnu.2018.02.017⟩
Clinical Nutrition, Elsevier, 2019, 38 (2), pp.564-574. ⟨10.1016/j.clnu.2018.02.017⟩
Clinical Nutrition, 2019, 38 (2), pp.564-574. ⟨10.1016/j.clnu.2018.02.017⟩
BACKGROUND: Citrulline (CIT), is not extracted by the splanchnic area, can stimulate muscle protein synthesis and could potentially find clinical applications in conditions involving low amino acid (AA) intake, such as in malnourished older subjects.
Publikováno v:
Rheumatology and Therapy
Rheumatology and Therapy, 2020, 7 (4), pp.741-757. ⟨10.1007/s40744-020-00245-0⟩
Rheumatology and Therapy, 2020, 7 (4), pp.741-757. ⟨10.1007/s40744-020-00245-0⟩
Injection-site pain (ISP) is a subjective side effect that is commonly reported with the subcutaneous administration of biological agents, yet it may only be a concern to some. Multiple factors related to the product formulation, such as pH, volume a
Autor:
Muriel Paul, Pascal Joly, Vincent Descamps, Mahtab Samimi, Jean-David Bouaziz, Emilie Sbidian, L. Le Cleach, Camille Roux, Saskia Ingen-Housz-Oro, Céline Girard, Julien Seneschal, Nicolas Dupin, Diane Kottler, Catherine Prost
Publikováno v:
JAMA Dermatol
Importance Erythema multiforme (EM) may become long term, with a recurrent or persistent course. First-line treatment for chronic EM is valaciclovir. There is no consensus for selection of second-line treatment of chronic EM. Objective The aim of thi
Autor:
Laetitia Penso, P. Claudepierre, L. Pina Vegas, Emilie Sbidian, Muriel Paul, P. Le Corvoisier
Publikováno v:
Annals of the Rheumatic Diseases. 80:317.2-317
Background:Psoriatic arthritis (PsA) is associated with other diseases of the spectrum of spondyloarthritis but also appears to be linked to an increased prevalence of numerous comorbidities and more specifically cardiovascular risk factors and event
Autor:
Muriel Paul, W Kini-Matondo, S Simpelaere, P Bardo-Brouard, C Cordonnier-Jourdin, Alain Astier, J Bataille
Publikováno v:
Annales Pharmaceutiques Françaises. 75:121-130
As drug delivery activity to outpatients in precarious situation is rising continuously, the goal of this work was to perform an assessment of the professional practices of the care pathway of these patients, called PASS in France (permanence d'acces
Autor:
M. Dalle-pecal, Catherine Divine, Muriel Paul, A. Pelissolo, C. Kowal, K Richard, S Wise, B Pignon, S Vanhulst
Publikováno v:
Section 4: Clinical Pharmacy Services.
Background In 2017 a patient’s death occurred in the psychiatry department of our establishment. After a morbidity-mortality review, the hypothesis of a cardiac arrest after intake of torsadogenic drugs has been suggested. Purpose The state of card
Publikováno v:
Pharmaceutics
Volume 12
Issue 11
Pharmaceutics, MDPI, 2020, 12 (11), ⟨10.3390/pharmaceutics12111060⟩
Pharmaceutics, 2020, 12 (11), ⟨10.3390/pharmaceutics12111060⟩
Pharmaceutics, Vol 12, Iss 1060, p 1060 (2020)
Volume 12
Issue 11
Pharmaceutics, MDPI, 2020, 12 (11), ⟨10.3390/pharmaceutics12111060⟩
Pharmaceutics, 2020, 12 (11), ⟨10.3390/pharmaceutics12111060⟩
Pharmaceutics, Vol 12, Iss 1060, p 1060 (2020)
Rapamycin has been used topically to treat facial angiofibromas associated with tuberous sclerosis for more than a decade. In the absence of a commercial form, a large number of formulations have been clinically tested. However, given the great heter